Warning: The NCBI web site requires JavaScript to function. more...
Circulating levels of adipocyte and epidermal fatty acid-binding proteins in relation to nephropathy staging and macrovascular complications in type 2 diabetic patients.
Yeung DC, Xu A, Tso AW, Chow WS, Wat NM, Fong CH, Tam S, Sham PC, Lam KS.
Diabetes Care. 2009 Jan;32(1):132-4. Epub 2008 Oct 17.PMID: 18931100 [PubMed - in process]Related articlesFree article
Effect of pitavastatin on urinary liver-type fatty acid-binding protein levels in patients with early diabetic nephropathy.
Nakamura T, Sugaya T, Kawagoe Y, Ueda Y, Osada S, Koide H.
Diabetes Care. 2005 Nov;28(11):2728-32.PMID: 16249547 [PubMed - indexed for MEDLINE]Related articlesFree article
Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes.
Tarnow L, Hovind P, Teerlink T, Stehouwer CD, Parving HH.
Diabetes Care. 2004 Mar;27(3):765-9.PMID: 14988299 [PubMed - indexed for MEDLINE]Related articlesFree article
Urinary L-FABP and anaemia: distinct roles of urinary markers in type 2 diabetes.
von Eynatten M, Baumann M, Heemann U, Zdunek D, Hess G, Nawroth PP, Bierhaus A, Humpert PM.
Eur J Clin Invest. 2009 Nov 11. [Epub ahead of print]PMID: 19912308 [PubMed - as supplied by publisher]Related articles
Serum adipocyte fatty acid binding protein as a new biomarker predicting the development of type 2 diabetes: a 10-year prospective study in a Chinese cohort.
Tso AW, Xu A, Sham PC, Wat NM, Wang Y, Fong CH, Cheung BM, Janus ED, Lam KS.
Diabetes Care. 2007 Oct;30(10):2667-72. Epub 2007 Jul 9.PMID: 17620449 [PubMed - indexed for MEDLINE]Related articlesFree article
Serum adipocyte fatty acid-binding protein levels are associated with nonalcoholic fatty liver disease in type 2 diabetic patients.
Koh JH, Shin YG, Nam SM, Lee MY, Chung CH, Shin JY.
Diabetes Care. 2009 Jan;32(1):147-52. Epub 2008 Oct 3.PMID: 18835952 [PubMed - in process]Related articlesFree article
Epidermal fatty-acid-binding protein: a new circulating biomarker associated with cardio-metabolic risk factors and carotid atherosclerosis.
Yeung DC, Wang Y, Xu A, Cheung SC, Wat NM, Fong DY, Fong CH, Chau MT, Sham PC, Lam KS.
Eur Heart J. 2008 Jul 4. [Epub ahead of print]PMID: 18603624 [PubMed - as supplied by publisher]Related articles
Urinary excretion of liver-type fatty acid-binding protein in contrast medium-induced nephropathy.
Nakamura T, Sugaya T, Node K, Ueda Y, Koide H.
Am J Kidney Dis. 2006 Mar;47(3):439-44.PMID: 16490622 [PubMed - indexed for MEDLINE]Related articles
Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study.
Xu A, Tso AW, Cheung BM, Wang Y, Wat NM, Fong CH, Yeung DC, Janus ED, Sham PC, Lam KS.
Circulation. 2007 Mar 27;115(12):1537-43.PMID: 17389279 [PubMed - indexed for MEDLINE]Related articlesFree article
Effect of pioglitazone on urinary liver-type fatty acid-binding protein concentrations in diabetes patients with microalbuminuria.
Nakamura T, Sugaya T, Kawagoe Y, Ueda Y, Koide H.
Diabetes Metab Res Rev. 2006 Sep-Oct;22(5):385-9.PMID: 16506273 [PubMed - indexed for MEDLINE]Related articles
Urinary fatty acids and liver-type fatty acid binding protein in diabetic nephropathy.
Sasaki H, Kamijo-Ikemori A, Sugaya T, Yamashita K, Yokoyama T, Koike J, Sato T, Yasuda T, Kimura K.
Nephron Clin Pract. 2009;112(3):c148-56. Epub 2009 Apr 24.PMID: 19390215 [PubMed - indexed for MEDLINE]Related articles
Serum adipocyte fatty acid-binding protein levels were independently associated with carotid atherosclerosis.
Yeung DC, Xu A, Cheung CW, Wat NM, Yau MH, Fong CH, Chau MT, Lam KS.
Arterioscler Thromb Vasc Biol. 2007 Aug;27(8):1796-802. Epub 2007 May 17.PMID: 17510463 [PubMed - indexed for MEDLINE]Related articlesFree article
Markers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years: association with mortality and decline of glomerular filtration rate.
Astrup AS, Tarnow L, Pietraszek L, Schalkwijk CG, Stehouwer CD, Parving HH, Rossing P.
Diabetes Care. 2008 Jun;31(6):1170-6. Epub 2008 Mar 10.PMID: 18332153 [PubMed - indexed for MEDLINE]Related articlesFree article
Urinary fatty acid-binding protein as a new clinical marker of the progression of chronic renal disease.
Kamijo A, Kimura K, Sugaya T, Yamanouchi M, Hikawa A, Hirano N, Hirata Y, Goto A, Omata M.
J Lab Clin Med. 2004 Jan;143(1):23-30.PMID: 14749682 [PubMed - indexed for MEDLINE]Related articles
Urinary liver-type fatty acid-binding protein levels for differential diagnosis of idiopathic focal glomerulosclerosis and minor glomerular abnormalities and effect of low-density lipoprotein apheresis.
Clin Nephrol. 2006 Jan;65(1):1-6.PMID: 16429835 [PubMed - indexed for MEDLINE]Related articles
Association between mannose-binding lectin and vascular complications in type 1 diabetes.
Hansen TK, Tarnow L, Thiel S, Steffensen R, Stehouwer CD, Schalkwijk CG, Parving HH, Flyvbjerg A.
Diabetes. 2004 Jun;53(6):1570-6.PMID: 15161763 [PubMed - indexed for MEDLINE]Related articlesFree article
Serum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes.
Nakamura A, Shikata K, Hiramatsu M, Nakatou T, Kitamura T, Wada J, Itoshima T, Makino H.
Diabetes Care. 2005 Dec;28(12):2890-5.PMID: 16306550 [PubMed - indexed for MEDLINE]Related articlesFree article
Deletion insertion polymorphism of the angiotensin converting enzyme gene and progression of diabetic nephropathy.
Björck S, Blohmé G, Sylvén C, Mulec H.
Nephrol Dial Transplant. 1997;12 Suppl 2:67-70.PMID: 9269704 [PubMed - indexed for MEDLINE]Related articles
Urinary connective tissue growth factor excretion correlates with clinical markers of renal disease in a large population of type 1 diabetic patients with diabetic nephropathy.
Nguyen TQ, Tarnow L, Andersen S, Hovind P, Parving HH, Goldschmeding R, van Nieuwenhoven FA.
Diabetes Care. 2006 Jan;29(1):83-8.PMID: 16373901 [PubMed - indexed for MEDLINE]Related articlesFree article
Adipocyte fatty acid-binding protein is associated with markers of obesity, but is an unlikely link between obesity, insulin resistance, and hyperandrogenism in polycystic ovary syndrome women.
Möhlig M, Weickert MO, Ghadamgadai E, Machlitt A, Pfüller B, Arafat AM, Pfeiffer AF, Schöfl C.
Eur J Endocrinol. 2007 Aug;157(2):195-200.PMID: 17656598 [PubMed - indexed for MEDLINE]Related articlesFree article
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on
» See more...